Home / Investors / Financial corner / Press releases / DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market

DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market